PreSize® Neurovascular for surgery planning
Common vascular diseases are currently treated using a minimally-invasive surgery where a stent is inserted into a patient’s blood vessel.
PreSize® Neurovascular is a medical device software that supports the planning of neurovascular surgeries involving stent devices. By predicting the behaviour of a particular stent in an individual patient’s anatomy with a precision rate of 96.75%, PreSize® helps to ensure surgeons select the optimal device for their patient.
In advance of a procedure, the best stent for a patient’s anatomy and surgical situation can be selected from a digital twin library of all certified stents. PreSize® provides vital information for successful surgical outcomes, such as deployed device length and degree of device apposition.
How it works
Supporting surgeons
PreSize® allows you to visualise and compare stents, providing the data needed to make the best decision for each individual patient.
Curious to learn more?
To find out more about us and what we do, please get in touch.
Supporting surgeons
Curious to learn more?
PreSize® allows you to visualise and compare stents, providing the data needed to make the best decision for each individual patient.
To find out more about us and what we do, please get in touch.
Our partners
We develop and validate our technology with NHS partners on an ongoing basis. Since the start, PreSize® Neurovascular has been designed in collaboration with interventional neuroradiologists at multiple NHS Trusts.
PreSize® received support from: NIHR, MRC, SBRI Healthcare, EIT Health, Innovate UK and The Royal Academy of Engineering.
We are currently on the DigitalHealth.London Accelerator programme that supports the most promising digital healthcare companies based in London. The accelerator programme has put us on the map for NHS trusts, which has led to exciting collaborations.
Validation study
Validation of the Deployment Algorithm within PreSize® Neurovascular
PreSize® Neurovascular was validated in collaboration with 4 different UK hospitals in a retrospective study. Pre- and post-operative data from patients treated with Pipeline Embolisation Device flow diverting stent (PED, Medtronic) were retrospectively analysed. Flow diverter deployed length was compared to the device length virtually deployed in PreSize® Neurovascular software. Good prediction of the deployed device length was obtained with a mean deployment accuracy of 96.75% and 95% confidence interval [95.90:97.59]). Presize® Neurovascular software yields highly accurate estimate of the stent length after deployment and, as such, provides interventional neuroradiologists with advanced preoperative planning support real time within minutes.
Who we are
Our Vision
A world where every patient and doctor is supported by the most advanced technologies and successful surgical outcomes are the norm
Our Mission
To provide clinicians with the cutting-edge technology they need to make life-saving decisions and offer their patients the highest standards of care
Our certifications
Our certifications
